Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Eli Lilly's GLP-1 outdoes Novo Nordisk's
Eli Lilly’s Zepbound Beats Novo Nordisk’s Wegovy in First Head-to-Head Study
People who took Zepbound lost 17 pounds more on average after 72 weeks of treatment than those who were given Novo Nordisk’s drug.
Eli Lilly's Zepbound Tops Novo Nordisk's Wegovy in Weight-Loss Trial
Eli Lilly's popular weight-loss drug Zepbound outperformed Danish drugmaker Novo Nordisk's Wegovy in a clinical trial, according results of the study released Wednesday.
Lilly’s Zepbound Beats Novo’s Wegovy in Head-to-Head Trial
Eli Lilly & Co. said its weight-loss drug Zepbound outperformed rival Novo Nordisk A/S’s Wegovy in the first head-to-head trial of the two blockbusters.
Catalent, Novo Nordisk and european union
European regulators approve $16.5 billion deal for Novo Holdings to buy Catalent
The European Commission on Friday unconditionally approved a controversial deal in which Novo Holdings, the parent company of Novo Nordisk, one of the
Novo Holdings' $16.5 billion Catalent buy wins EU antitrust approval
Novo Holdings on Friday gained unconditional EU antitrust approval for its $16.5 bln acquisition of U.S. contract drug maker Catalent after EU regulators said they did not see any competition issues.
EU approves Novo Holdings’ acquisition of Catalent
The European Commission has approved unconditionally, under the EU Merger Regulation, the proposed acquisition of Catalent (CTLT) by Novo
JD Supra
9h
Novo Nordisk Urges FDA to Ban Compounded Semaglutide – What Weight-Loss Clinic Owners Need to Know
Novo Nordisk, the manufacturer of Ozempic and Wegovy, has petitioned the Food and Drug Administration (FDA) to add ...
FiercePharma
11h
AbbVie’s Skyrizi retains DTC spending crown, as Novo’s Wegovy sees first entry
That’s according to the latest data from real-time ad trackers iSpot.TV. Their analysts found AbbVie’s immunology drug duo ...
2d
on MSN
Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 million
By Gnaneshwar Rajan and Maggie Fick (Reuters) -U.S.-based vaccine maker Novavax said on Wednesday it will sell its ...
STAT
2d
Pharmalittle: We’re reading about a Zepbound-Wegovy faceoff, compounders slamming Novo, and more
Eli Lilly said its weight loss drug Zepbound led to 47% greater weight reduction than rival medicine Wegovy, made by Novo ...
globalconstructionreview
2d
Wegovy-maker Novo Nordisk to build €390m quality control centre
Novo Nordisk, the Danish company that makes diabetes drug Ozempic and obesity treatment Wegovy, has begun work on a 5.3ha ...
EconoTimes
1d
Denmark’s Economy Explodes Thanks to Novo Nordisk—‘All Eyes on Wegovy’s Billion-Dollar Boom!’
Denmarks economic prospects are surging, with the government revising GDP growth forecasts upwards for 2024 and 2025, largely ...
1d
Denmark raises 2025 GDP outlook, benefits from Novo Nordisk's growth
Denmark has again raised its outlook for economic growth, fuelled by the expansion of the country's pharmaceutical industry ...
The Cincinnati Enquirer
5d
Why your co-pay for weight loss drugs like Wegovy just went through the roof
For Debbie Halstead, the weight loss medication
Wegovy
has been nothing short of a miracle. The Cool Ridge, West Virginia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback